Dr. Rohan, et al. “THE COMPREHENSIVE STUDY ON NOVEL ANGIOGENIC AND ANTI-ANGIOGENIC BIOMARKERS (E.G., SFLT-1 PLGF RATIOS) TO PREDICT AND MANAGE PRE-TERM PRE-ECLAMPSIA”. Journal of Population Therapeutics and Clinical Pharmacology, vol. 32, no. 11, Sept. 2026, pp. 2576-85, https://doi.org/10.69980/es7wh926.